Unedited news and product information from vendors.
ePharmaSolutions Announces the Deployment of its Enterprise Clinical Trial Portal for Two Global Biopharmaceutical Companies
Aug 24, 2011 (03:08 PM EDT)
CONSHOHOCKEN, Pa., Aug. 24, 2011 /PRNewswire/ -- ePharmaSolutions announced the successful deployment of its Enterprise level Clinical Trial Portal (CTP) for a top five global pharmaceutical company on more than 900 studies to 90 countries and a second client deployment scheduled for September 2011.
Clinical Trial Portals help streamline and accelerate the clinical development process for sponsors, study sites and third party vendors by providing a common technology platform from which to conduct their trials. Historically these portals were deployed at the study level, resulting in measurable improvements in time and cost for that study. Today, biopharmaceutical companies are standardizing on single vendors to provide these portal solutions across the enterprise to help realize the time and cost savings across the enterprise while simplifying the process for study teams and site users.
"We are seeing more of our sponsors and CRO partners migrate from single study workspaces to enterprise CTP deployments this year than ever," stated Lance Converse, ePharmaSolutions' Founder and CEO. "Enterprise deployments of the CTP help force the standardization of business processes across the clinical development lifecycle while reducing cost and accelerating timelines," added Converse.
ePharmaSolutions' Clinical Trial Portal is currently used by more than 235,000 users in 120 countries and helps biopharmaceutical companies improve and accelerate site activation, study training, safety letter distribution, and patient recruitment while integrating all of the third-party vendor applications (EDC, IXRS, Labs, etc.) to help centralize study management/reporting and provide users with one website and one set of credentials for all of their clinical study needs.
"Enterprise deployments typically include integrations with the clients' CTMS, EDC and IXRS systems, which can significantly reduce the amount of data entry required across the various systems used to conduct trials in today's technology driven clinical trials environment," stated Steven Beales, ePharmaSolutions Vice President of Information Technology. "The integrations allow the study teams to add or edit a user in the CTP and authenticate that change to all of the systems used in the study, eliminating redundant manual data entry and multiple account registrations forms," Beales added.
The typical cost saving for using the Clinical Trial Portal on a one year 75 site global oncology study can exceed $1 million dollars (US) when compared to the traditional cost of paper based site feasibility, study document completion, in-person training and overnighted safety letter distribution.
ePharmaSolutions is a leading provider of technology-based clinical services that helps improve the way sites are selected, trained, activated and managed to exceed enrollment goals. ePharmaSolutions won the 2009 Bio-IT World Award for best clinical trial technology and has activated and trained more than 235,000 clinical researchers in 120 countries for the top 20 pharmaceutical companies in the world. ePharmaSolutions is headquartered in Philadelphia with offices in London. For more information visit www.epharmasolutions.com or call Lance Converse at 610-832-9915. Follow us on LinkedIn and Facebook.